Target intelligence / Profile preview

Rab3 GTPase-activating protein catalytic subunit 1 (RAB3GAP1)

Target
RAB3GAP1
Molecular classification
Enzyme (specifically, GTPase-activating protein: GAP), Membrane trafficking regulator
01

Overview

Rab3 GTPase-activating protein catalytic subunit 1 (RAB3GAP1) is the catalytic component of the Rab3GAP complex, a heterodimer composed of RAB3GAP1 (130 kDa) and RAB3GAP2 (150 kDa). This complex regulates Rab3 subfamily GTPases by stimulating the conversion of Rab3-GTP to Rab3-GDP, thereby controlling regulated exocytosis of neurotransmitters and hormones. Rab3GAP1 also displays guanine nucleotide exchange factor (GEF) activity for Rab18, promoting its recruitment and activation at membrane compartments such as the ER and Golgi. Functions of RAB3GAP1 include organizing vesicle trafficking, cellular lipid storage and release, autophagy, and neurodevelopment. Pathogenic mutations in RAB3GAP1 disrupt normal protein function and are the primary cause of Warburg micro syndrome, a rare autosomal recessive disorder with postnatal growth retardation, microcephaly, congenital cataracts, optic atrophy, spastic paraplegia, and hypogonadism. Martsolf syndrome is a milder form with reduced protein function. No drugs directly targeting RAB3GAP1 are reported, and no established biomarkers or safety concerns exist beyond its genetic deficiency syndromes.

Other names
KIAA0066RAB3GAPRab3-GAPRAB3GAP130WARBM1P130rab3-GAP p130RAB3 GTPase activating protein subunit 1 (catalytic)Rab3 GTPase-activating protein 130 kDa subunit
02

Biological functions

Regulation of small GTPase activity (Rab proteins)Vesicle traffickingNeurotransmitter and hormone exocytosisLipid droplet metabolismER-to-Golgi traffickingRegulation of autophagyCell compartment organizationNeurodevelopmental processes (proliferation, migration, differentiation)
03

Disease associations

Warburg micro syndromeMartsolf syndromeEye abnormalities (e.g., coloboma, keratoconus)Brain development disordersReproductive system abnormalities
04

Safety considerations

Loss-of-function mutations result in congenital syndromes characterized by severe neurodevelopmental and ocular abnormalities, no direct therapeutic targeting described
05

Biomarkers

Mutations in RAB3GAP1 for diagnosis of Warburg micro syndromeGenetic testing for RAB18 deficiency

Beyond the preview

Go deeper on Rab3 GTPase-activating protein catalytic subunit 1 (RAB3GAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rab3 GTPase-activating protein catalytic subunit 1 (RAB3GAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call